SCHEMBL25170375

SCHEMBL25170375

COc1ccc(-c2cnc3c(Nc4ccc(C(=O)O)c(Br)c4)nccn23)c(F)c1F

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PTK6 Q13882 3/20 0.40
▸ SYK P43405 6/20 0.38
▸ MAPKAPK5 Q8IW41 1/20 0.37
▸ DHODH Q02127 1/20 0.37
▸ TTK P33981 1/20 0.37
▸ IDO1 P14902 3/20 0.36
▸ PDE4B Q07343 2/20 0.35
▸ PDE4D Q08499 2/20 0.35
▸ AURKB Q96GD4 1/20 0.35
▸ HTT P42858 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ AURKA O14965 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30386051 0.93 PTK6 (0.40) PTK6SYKMAPKAPK5TTKIDO1
SCHEMBL25170422 0.91 SYK (0.41) PTK6SYKMAPKAPK5DHODHTTK
Hydrochloric Acid SCHEMBL30385672 0.90 SYK (0.40) PTK6SYKMAPKAPK5DHODHTTK
SCHEMBL22123969 0.90 PTK6 (0.48) PTK6SYKMAPKAPK5DHODHTTK
SCHEMBL30385514 0.90 SYK (0.40) PTK6SYKMAPKAPK5DHODHTTK
SCHEMBL30385303 0.90 PTK6 (0.48) PTK6SYKMAPKAPK5DHODHTTK
SCHEMBL30168175 0.89 PTK6 (0.39) PTK6SYKMAPKAPK5DHODHTTK
SCHEMBL22123142 0.89 PTK6 (0.39) PTK6SYKMAPKAPK5DHODHTTK
Hydrochloric Acid SCHEMBL22124453 0.88 PTK6 (0.39) PTK6SYKMAPKAPK5DHODHTTK
Hydrochloric Acid SCHEMBL30386239 0.88 PTK6 (0.39) PTK6SYKMAPKAPK5DHODHTTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230141600-A1 IMIDAZOPYRAZINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230141600-A1 IMIDAZOPYRAZINE DERIVATIVES IKZF3, RRP15, IK PTK6 925/4885SYK 256/4885MAPKAPK5 508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback